1 / 1

Newsletter : An Abundance of Rare

There are over 7000 rare diseases affecting millions worldwide. Though they appear rare, still rare diseases are very much prevalent. Rare diseases pose a huge burden on the global healthcare system, affecting the quality of lives of millions of patients collectively.<br>There are many companies working on finding cure for rare diseases.<br>The Top 10 Companies in Rare Disease Segment are:<br>Novartis, Roche, Celgene, Shire (Takeda), BMS, Merck, J&J, Pfizer, Sanofi and Alexion. Additionally, there are many new companies working to get a rare disease therapy to market.<br>Have a Copy our Newsletter : https://www.delveinsight.com/whitepaper-newsletter/an-abundance-of-rare

sthakur
Télécharger la présentation

Newsletter : An Abundance of Rare

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Newsletter : An Abundance of Rare Ankit Nigam May 5 · 1 min read There are over 7000 rare diseases affecting millions worldwide. Though they appear rare, still rare diseases are very much prevalent. Rare diseases pose a huge burden on the global healthcare system, affecting the quality of lives of millions of patients collectively. There are many companies working on finding cure for rare diseases. The Top 10 Companies in Rare Disease Segment are: Novartis, Roche, Celgene, Shire (Takeda), BMS, Merck, J&J, Pfizer, Sanofi and Alexion. Additionally, there are many new companies working to get a rare disease therapy to market. Have a Copy our Newsletter : https://www.delveinsight.com/whitepapernewsletter/an- abundance-of-rare https://www.delveinsight.com/whitepaper-newsletter/an-abundance-of-rare

More Related